Fort, L.P. Biogen Inc. Transaction History

Fort, L.P.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $230,756 - $260,445	911 New	911 $234,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $224,815 - $288,921	-1,004 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $276,198 - $360,192	-976 Reduced 49.29%	1,004 $284,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $317,534 - $508,434	-1,226 Reduced 38.24%	1,980 $686,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $108,112 - $126,660	-445 Reduced 12.19%	3,206 $897,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $293,907 - $442,403	1,244 Added 51.68%	3,651 $894,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $637,301 - $735,843	2,407 New	2,407 $683,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $17,588 - $23,293	-68 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $98,399 - $124,820	-366 Reduced 84.33%	68 $22,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $117,952 - $162,981	-536 Reduced 55.26%	434 $129,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $55,447 - $62,189	255 Added 35.66%	970 $226,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $92,540 - $102,005	-422 Reduced 37.12%	715 $167,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $122,874 - $192,190	567 Added 99.47%	1,137 $269,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $3,063 - $3,880	-11 Reduced 1.89%	570 $172,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $75,432 - $98,644	257 Added 79.32%	581 $205,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $83,436 - $99,438	324 New	324 $94,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.